VEGFR Inhibitors

查看全部
Product Name VEGFR1/Flt-1 VEGFR2/KDR/Flk-1 VEGFR3/Flt-4 Purity
(E)-FeCP-oxindole
(Rac)-SAR131675
(rac)-ZK-304709
(S)-SAR131675 99.72%
(Z)-FeCP-oxindole 99.62%
(Z)-Guggulsterone 99.41%
(Z)-Orantinib 99.44%
(Z)-SU14813
(±)-Aiphanol
(±)-Glaziovine
1,3,5-Tricaffeoylquinic acid
MET kinase-IN-4 99.00%
19-epi-Scholaricine 99.14%
10Z-Hymenialdisine
3-Methylthienyl-carbonyl-JNJ-7706621
4-Methoxycinnamic acid ethyl ester 98.72%
4-TCPA
4SC-203 98.98%
5-O-Methylvisammioside 99.90%
5Z-7-Oxozeaenol 99.30%
5α-Hydroxycostic acid 95.17%
6'-Sialyllactose 99.60%
6'-Sialyllactose sodium 98.05%
7-Hydroxyneolamellarin A
A-176120
AAL993 99.14%
AC-P19M
Acrizanib 99.84%
AFG210
Aflibercept (VEGF Trap) 97.66%
AG-13958 99.69%
AG-13958 (mono(hydrochloride))
AG-28262
AG01 95.10%
AGN-745
AGN-745 sodium
AGN-745 sodium scrambled negative control
AGW-11
AhR modulator-1
AK-778-XXMU 99.96%
ALN-3133 sodium
ALN-3133 sodium scrambled negative control
Altiratinib 99.29%
AM9928
AMG-47a 99.19%
AMG-Tie2-1 99.5%
Angiogenesis inhibitor 6
Anomalin A
Ansornitinib 98.23%
Anti-DCBLD2/ESDN Antibody (FA19-1)
Anti-Human/Rat VEGF Antibody (A.4.6.1)
Anti-Mouse Delta-like protein 4/DLL4 Antibody (HMD4-2)
Anti-Mouse VEGF Antibody (G6-31)
Anti-Mouse VEGF-A Antibody (2G11-2A05) 97.40%
Anti-Mouse VEGFR-2 Antibody (DC101) 99%
Anti-Mouse VEGFR-2 Antibody (DC101-Mouse IgG2a)
Anti-VEGFB Antibody (CSL346) ≥99.0%
Anti-VEGFR1/FLT1 Antibody
Anti-VEGFR2/KDR/CD309 Antibody
Anti-VEGFR2/KDR/CD309 Antibody (AT001)
Antiangiogenic agent 9
Anticancer agent 276
Antiproliferative agent-20
Antiproliferative agent-54
Antiproliferative agent-57
Apatinib-d8 free base 92.03%
Apolipoprotein KV domain (67-77)
Apoptotic agent-4
APX004
Arginyl-Glutamine
Arginyl-Glutamine TFA
ASKG-712
AST 487 98.90%
AT-533 98.38%
ATWLPPR Peptide 99.63%
Auriculasin 98.54%
AXL/Angiokinase-IN-1
Azaspirene
AZD2932 98.16%
B-Raf IN 17
BAT5906
Bevacizumab vedotin 97.72%
Bevasiranib
Bevasiranib sodium 94.50%
Bevasiranib sodium scrambled negative control
BFH772 96.67%
BHEPN
BI-836880
BMS-195614 99.5%
BMS-605541 99.57%
BMS-645737
BMS-690514 99.68%
BMS-794833 99.52%
BPTQ
Bucillamine 99.04%
c-Met-IN-11
c-Met-IN-31
C-VGB3
CA IX/VEGFR-2-IN-2
CA IX/VEGFR-2-IN-3
Cabozantinib hydrochloride
Cabozantinib-d4 S-malate
Capeserod 98.66%
Casdatifan 96.37%
CAY10781 98.04%
CBO-P11
CDK2/FLT4/PDGFRA-IN-1
CEP-11981 99.88%
CEP-11981 tosylate
CEP-14083
CEP-14513
CEP-5214
CEP-7055
Chloramphenicol/BSA
Chloropyramine hydrochloride 99.64%
cis-SU4312
Clausenidin
CLM3
Coibamide A
COX-2-IN-55 99.20%
CP-547632 99.94%
CP-547632 hydrochloride 99.79%
CP-547632 TFA 98.04%
CPD-002
Cremastranone
CS2009
cyclo(CLLFVY) 99.37%
CZC-8004 99.81%
Darlifarnib
DHW-221
DMH4 98.20%
DOTA-TMVP1446
DSPE-PEG1000-Mal-Cys-ATWLPPR
DSPE-PEG2000-Mal-Cys-ATWLPPR
DSPE-PEG3400-A7R
DSPE-PEG5000-A7R
Dth
DW10075
Efadirelaxin alfa
Efclarofusp alfa
Efdamrofusp alfa 99.89%
EG00229
EG01449
EG01449 Free acid
EGFR T790M/VEGFR-2-IN-1
EGFR-IN-116
EGFR-IN-174
EGFR-IN-192
EGFR-IN-26
EGFR-IN-57
EGFR-IN-94
EGFR/VEGFR2-IN-1
EGFR/VEGFR2-IN-10
EGFR/VEGFR2-IN-11
EGFR/VEGFR2-IN-12
EGFR/VEGFR2-IN-13
EGFR/VEGFR2-IN-2
EGFR/VEGFR2-IN-3
EGFR/VEGFR2-IN-4
EGFR/VEGFR2-IN-5
EGFR/VEGFR2-IN-6
EGFR/VEGFR2-IN-7
EGFR/VEGFR2-IN-8
EGFR/VEGFR2-IN-9
Elpamotide
ENMD-2076 99.99%
ENMD-2076 Tartrate 99.66%
Enzyme modulator-1
EOC317 98.01%
Erenapurstat 99.67%
EVT801
EYE1090
EYE1118
Famitinib malate
FGFR1/VEGFR2-IN-1
FGFR1/VEGFR2-IN-2
FGFR1/VEGFR2-IN-3
FGFR3-IN-2
FGFRs-IN-1
Flt2-11 99.71%
FLT3-IN-37
FLT3/VEGFR2-IN-1
Foretinib 99.45%
Foretinib phosphate
FR 111142
Fruquintinib-d6 99.47%
Fumarranol
Gandotinib 99.86%
Gersizangitide 97.16%
Girancitug 98.80%
GNQWFI 99.45%
Golvatinib 99.86%
GSK248233A
GSK2646264 99.74%
Guluronic acid sodium 98.0%
GW297361 98.05%
GW549390X
GW701427A
GW768505A free base 99.26%
GW806742X 99.38%
GW806742X hydrochloride 98.30%
GW809897X
hCA/VEGFR-2-IN-1
hCA/VEGFR-2-IN-2
hCA/VEGFR-2-IN-3
hCA/VEGFR-2-IN-4
hCA/VEGFR-2-IN-5
HDAC-IN-35
Henatinib
Henatinib maleate
hPV19
HSP110-IN-1
HSP90-IN-13
hVEGF-IN-1 99.25%
hVEGF-IN-2
hVEGF-IN-3 99.56%
Hydroxytanshinone IIA 99.83%
I194496 98.52%
Ilorasertib 99.86%
Ilorasertib hydrochloride 98.48%
IMS2186 99.96%
Inlecitug 98.62%
Isolinderalactone 98.79%
JB-1 99.63%
JI-101 98.99%
JI-101 hydrochloride
JK-P3 99.75%
JNJ 17029259
JNJ-38158471 97.02%
Jolkinolide A 98.0%
JTE-907 98.54%
K-106
K00546 99.48%
Ki20227 99.51%
Ki8751 99.76%
KLTWQELYQLKYKGI 99.89%
KRN-633 99.45%
KST012174 hydrochloride
L-783277
Liensinine perchlorate 99.67%
LM-299 95.78%
Low molecular weight protamine 98.07%
Low molecular weight protamine acetate 98.64%
Lucitanib dihydrochloride 98.12%
LY2457546
LY3022856 98.84%
LYN00101
MAZ51 99.76%
MET kinase-IN-3
MG-262 95.0%
MGCD-265 analog 98.49%
Midostaurin-13C6
ML786
ML786 dihydrochloride
MMPP 98.06%
MSB-0254
Multi-kinase inhibitor 3
Multi-kinase-IN-12
Multi-kinase-IN-2
Multi-kinase-IN-3
Multi-kinase-IN-4
Multi-kinase-IN-5
Multi-kinase-IN-7
Multi-kinase-IN-8
Multi-target kinase inhibitor 2 99.82%
Multi-target kinase-IN-7
Multi-target kinase-IN-8
MW02
Naphazoline-d4 hydrochloride
Nastorazepide 99.95%
Nastorazepide hemicalcium
NBM-T-BMX-OS01 99.74%
Nef-M1
NKP608 99.88%
NODAGA-tris(t-Bu ester) 96.28%
Notoginsenoside R4 99.34%
NPA101.3
NRPa-308 98.96%
NSC 850745
NVP-AAD777
NVP-ACC789 99.52%
NVP-BAW2881 98.54%
NY0123
NYLTHRQ
Obtustatin 99.94%
ODM-203 99.62%
Oglufanide disodium
Orantinib 98.52%
Orobol 98.14%
P8RI 99.49%
Palverafusp alfa 98.00%
Pamufetinib 98.28%
Pamufetinib mesylate 99.17%
PARP/VEGFR3-IN-1
Pazopanib-d3 hydrochloride
PD173074 99.86%
PDGFRα/β/VEGFR-2-IN-1
Pegaptanib sodium 90.51%
Pegaptanib sodium scrambled negative control
Pentagamavunon-1 98.95%
Peptide HRH
Peptide HRH acetate 97.16%
PF 00337210
PF 477736 99.04%
PF-03814735 99.45%
PI3K/VEGFR2-IN-1
Poly-L-lysine hydrobromide (MW 30000-70000)
Pomalidomide-C5-Dovitinib
PP121 99.51%
PP487
PROTAC VEGFR-2 degrader-1
PROTAC VEGFR-2 degrader-2
PROTAC VEGFR-2 degrader-3 99.09%
PTC299 99.71%
Pumitamig 99.6%
PX-478 99.58%
PX-478 free base
Pz-1 99.90%
R1530 98.29%
R916562
RAF265 99.80%
Ranibizumab (anti-VEGF) 99.60%
RC148 99.72%
Regorafenib mesylate
rel-Talmapimod hydrochloride
Rhamnazin 99.00%
RK-20448 99.38%
RO5323441 95.85%
S7 98.10%
SA-PA
SA-VA
SAR131675 99.85%
Scospondistatin
SCR-1481B1 99.95%
SCR-1481B1 free base 99.99%
Segetalin A 99.92%
Si5-N14
Sitravatinib 99.57%
Sitravatinib malate
SJ-C1044 98.63%
SKLB646
Sozinibercept 98.52%
SPHINX31 99.25%
SSGJ-707 ≥99.0%
ST6GAL1-IN-1 99.22%
SU 5402
SU 5402 99.78%
SU10944
SU11606
SU11652 99.18%
SU14813 99.11%
SU14813 maleate 99.04%
SU1498 98.84%
SU4312 99.74%
SU5204 99.46%
SU5205 98.02%
SU5208 99.48%
SU5214 98.0%
SU5408 98.0%
Sulfatinib 99.52%
Sunitinib glucuronate 95.0%
Sunitinib Malate 99.74%
Sunitinib-platinum(IV) prodrug-1
Sutetinib 99.27%
Sutetinib maleate
SYHA1813 99.46%
SYHA1815
T-1-MBHEPA
T-1-MCPAB
T-1840383
Tafetinib 96.20%
Tafetinib analogue 1
TAK-593 99.66%
Takeda-6D 99.41%
Taligantinib
TAT-N24
Tesevatinib 99.41%
Tesevatinib tosylate
TG 100572
TG 100572 Hydrochloride 98.76%
TG 100801 98.61%
TG 100801 Hydrochloride
TG 100948
TGP-377
Theasaponin E1 99.08%
THR-317
TIE-2/VEGFR-2 kinase-IN-1 99.91%
TIE-2/VEGFR-2 kinase-IN-2 99.81%
TIE-2/VEGFR-2 kinase-IN-3
TIE-2/VEGFR-2 kinase-IN-4
TIE-2/VEGFR-2 kinase-IN-5
Tinengotinib 99.57%
Tivozanib hydrate 99.0%
Tivozanib hydrochloride hydrate 99.83%
TMVP1446
Tosposertib 99.89%
Tovecimig 97.39%
trans-Trimethoxyresveratrol 99.35%
TRK II-IN-1
TU-100
Tubulin/VEGFR-2-IN-1
Tubulin/VEGFR-2-IN-2
Tyrphostin A9 99.91%
Tyrphostin AG1433 99.08%
UB-925
UniPR1331 98.57%
Valancitug 97.61%
VEGF-IN-1
VEGFR-2 ligand-2
VEGFR-2-IN-10
VEGFR-2-IN-11
VEGFR-2-IN-12
VEGFR-2-IN-13
VEGFR-2-IN-14
VEGFR-2-IN-15
VEGFR-2-IN-16
VEGFR-2-IN-17
VEGFR-2-IN-18
VEGFR-2-IN-19
VEGFR-2-IN-20
VEGFR-2-IN-21
VEGFR-2-IN-22
VEGFR-2-IN-23
VEGFR-2-IN-24
VEGFR-2-IN-25
VEGFR-2-IN-26
VEGFR-2-IN-27
VEGFR-2-IN-28
VEGFR-2-IN-29 99.36%
VEGFR-2-IN-30
VEGFR-2-IN-31
VEGFR-2-IN-32
VEGFR-2-IN-33
VEGFR-2-IN-35
VEGFR-2-IN-36
VEGFR-2-IN-37 99.11%
VEGFR-2-IN-38
VEGFR-2-IN-40
VEGFR-2-IN-41
VEGFR-2-IN-42
VEGFR-2-IN-43
VEGFR-2-IN-44
VEGFR-2-IN-45
VEGFR-2-IN-46
VEGFR-2-IN-47
VEGFR-2-IN-5
VEGFR-2-IN-5 hydrochloride 99.51%
VEGFR-2-IN-50
VEGFR-2-IN-51
VEGFR-2-IN-52
VEGFR-2-IN-53
VEGFR-2-IN-55
VEGFR-2-IN-56
VEGFR-2-IN-57
VEGFR-2-IN-58
VEGFR-2-IN-59
VEGFR-2-IN-6 99.89%
VEGFR-2-IN-60
VEGFR-2-IN-61
VEGFR-2-IN-62
VEGFR-2-IN-63
VEGFR-2-IN-64
VEGFR-2-IN-65
VEGFR-2-IN-66
VEGFR-2-IN-67
VEGFR-2-IN-69
VEGFR-2-IN-70
VEGFR-2-IN-71
VEGFR-2-IN-72
VEGFR-2-IN-73
VEGFR-2-IN-74
VEGFR-2-IN-76
VEGFR-2-IN-77
VEGFR-2-IN-78
VEGFR-2-IN-79
VEGFR-2-IN-80
VEGFR-2-IN-81
VEGFR-2-IN-83
VEGFR-2-IN-85
VEGFR-2-IN-87
VEGFR-2-IN-9
VEGFR-2/AKT-IN-1
VEGFR-2/AKT-IN-2
VEGFR-2/AURKA-IN-1
VEGFR-2/BRAF-IN-1
VEGFR-2/BRAF-IN-2
VEGFR-2/c-Met-IN-1
VEGFR-2/c-Met-IN-2
VEGFR-2/c-Met/EGFR-IN-1
VEGFR-2/DHFR-IN-1
VEGFR-2/DHFR-IN-2
VEGFR-2/InhA-IN-1
VEGFR-2/P-gp-IN-1
VEGFR-2/STAT-3-IN-1
VEGFR-3-IN-1 98.76%
VEGFR-IN-1 99.07%
VEGFR-IN-3
VEGFR-IN-5
VEGFR-IN-6
VEGFR-IN-7
VEGFR/PARP-IN-1
VEGFR/PD-L1-IN-1
VEGFR/PDGFR-IN-1
VEGFR2-IN-1
VEGFR2-IN-2 99.26%
VEGFR2-IN-3
VEGFR2-IN-4
VEGFR2-IN-7 99.79%
VEGFR2-IN-84
VEGFR2-IN-86
VEGFR2/HDAC-IN-1
VEGFR2/HDAC1-IN-1
VGB4
VGX-100 99.54%
VGX200
Vorolanib 99.78%
VS 8
VT3989 99.61%
VU 0364439 99.42%
Vulinacimab 99.40%
VX70
WHI-P180 99.84%
WHI-P180 hydrochloride
XENP9493
XL 999 99.01%
YF-452
YLL545
YLT192
YM-359445 dihydroxybutanedioate
YS07
Zanzalintinib 99.91%
ZD-4190 98.08%
ZD-4190 hydrochloride
Zerumin A
Zifibancimig 99.00%
Zinc borate
ZINC09875266
Ziv-aflibercept 95.00%
ZK-261991
ZM-306416 hydrochloride
ZM323881
ZM323881 hydrochloride 99.63%
Brivanib (alaninate) 99.45%
Tanshinone IIA 99.78%
Lenvatinib-d4 99.59%
Lenvatinib-d5
Lenvatinib-15N,d4 98.01%
Lenvatinib 99.75%
Lenvatinib N-oxide
Lenvatinib mesylate 99.91%
Motesanib Diphosphate 99.86%
Sodium Selenite 99.00%
Talmapimod 98.68%
Talmapimod hydrochloride
Varisacumab 97.28%
Vanucizumab 95.12%
Ivonescimab 99.13%
Rabbit Thrombin
Vandetanib 99.85%
Vandetanib-d4
Vandetanib-d6
Vandetanib-13C6
Vandetanib trifluoroacetate
Vandetanib hydrochloride
Linifanib 99.39%
Linifanib
Linifanib-d4
Monosialoganglioside GM3 (bovine)
Carebastine 99.23%
Cabozantinib 99.97%
Cabozantinib-d4
Cabozantinib-d6 98.14%
Cabozantinib S-malate 99.90%
Flavokawain C 99.53%
Guluronic acid
Semaxinib 99.92%
ZM 306416 99.80%
Caudatin 99.95%
Fursultiamine 99.71%
Fruquintinib 99.98%
OSI-930 98.33%
Thiabendazole 99.94%
Tubeimoside I 99.96%
Tarcocimab 98.35%
Dovitinib-d8
Dovitinib 99.88%
Dovitinib lactate 99.75%
Dovitinib lactate hydrate
Dovitinib dilactic acid
Mollugin 99.79%
Olinvacimab ≥95.0%
Oglufanide 98.93%
Ningetinib 99.63%
Ningetinib (Standard)
Hypothemycin 98.0%
Ningetinib Tosylate 99.59%
Ningetinib Tosylate (Standard)
Murine Thrombin
Nintedanib 99.90%
Nintedanib-d3
Nintedanib-13C,d3
Nintedanib-d8 99.90%
Nintedanib esylate 99.96%
BIBF 1202 99.82%
BIBF 1202-13C,d3 99.70%
BIBF 1202-d3
Brolucizumab 99.90%
Brivanib 99.45%
Pazopanib 99.91%
Pazopanib-d6 98.0%
Pazopanib-13C,d3
Pazopanib-d3
Ponatinib-d8 99.16%
Ponatinib 99.67%
Parsatuzumab 97.40%
Conbercept 98.42%
Isomangiferin 99.60%
Lucitanib 98.94%
Toceranib 97.41%
Toceranib-d8 99.08%
Toceranib phosphate 99.23%
Gamabufotalin 99.30%
Ponatinib hydrochloride 99.76%
Pulocimab 98.42%
Telatinib 99.37%
Tivozanib 99.80%
Tivozanib-d6
Quercimeritrin 99.48%
Chloramphenicol 99.96%
Threo-Chloramphenicol-d6
Mersalyl 89.25%
Faricimab 97.97%
Famitinib 98.13%
Taurocholic acid-d5 sodium
Taurocholic acid-d8 sodium 98.80%
Taurocholic acid sodium 99.82%
Taurocholic acid-13C2,15N sodium
Taurocholic acid-d4 sodium
Canine Thrombin
Regorafenib-d3 98.0%
Regorafenib-13C,d3
Regorafenib 99.93%
Regorafenib N-oxide and N-desmethyl (M5)
Regorafenib N-oxide and N-desmethyl (M5)-d3-1
Regorafenib Hydrochloride 99.09%
Regorafenib monohydrate 99.94%
Ripretinib 98.71%
Vatalanib dihydrochloride 99.68%
Vatalanib succinate
Vatalanib hydrochloride
Vatalanib 99.93%
Vatalanib-d4
Glycine 99.93%
Licoflavone A 99.95%
Telatinib mesylate 99.74%
Medrysone 99.79%
Sorafenib tosylate 99.98%
Sorafenib-d3 tosylate
Thymoquinone 99.80%
Pazopanib-13C,d3 hydrochloride 97.51%
Pazopanib Hydrochloride 99.99%
Naphazoline hydrochloride 99.38%
Naphazoline nitrate 99.12%
Hypocrellin A 99.73%
Raddeanin A 98.68%
Midostaurin 99.81%
Sotiburafusp alfa 97.37%
Sorafenib-d3 98.16%
Sorafenib-13C,d3 98.35%
Sorafenib-d4 99.9%
Sorafenib 99.84%
Ethyl cinnamate 99.80%
Sunitinib-d10 99.89%
Sunitinib-d4
Sunitinib 99.04%
Icrucumab 99.9%
Suvemcitug 96%
Alizarin 99.48%
Motesanib 99.96%
Liensinine 99.97%
Liensinine Diperchlorate 99.96%
Naphazoline 99.74%
Terrestrosin D 99.30%
Caulerpin
Cediranib 99.87%
Cediranib maleate 99.95%
Chiauranib 98.97%
Bevacizumab (Anti-VEGFA) 99.07%
Bevacizumab 98.90%
Dilpacimab 96.88%
Jujuboside B 99.92%
Alacizumab
Axitinib-13C,d3 97.80%
Axitinib-d3 98.07%
Axitinib 99.84%
Aflibercept 96.9%
Albendazole 99.05%
Ramucirumab (anti-VEGFR) 99.9%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础